Unknown

Dataset Information

0

A biological function based biomarker panel optimization process.


ABSTRACT: Implementation of multi-gene biomarker panels identified from high throughput data, including microarray or next generation sequencing, need to be adapted to a platform suitable in a clinical setting such as quantitative polymerase chain reaction. However, technical challenges when transitioning from one measurement platform to another, such as inconsistent measurement results can affect panel development. We describe a process to overcome the challenges by replacing poor performing genes during platform transition and reducing the number of features without impacting classification performance. This approach assumes that a diagnostic panel reflects the effect of dysregulated biological processes associated with a disease, and genes involved in the same biological processes and coordinately affected by a disease share a similar discriminatory power. The utility of this optimization process was assessed using a published sepsis diagnostic panel. Substitution of more than half of the genes and/or reducing genes based on biological processes did not negatively affect the performance of the sepsis diagnostic panel. Our results suggest a systematic gene substitution and reduction process based on biological function can be used to alleviate the challenges associated with clinical development of biomarker panels.

SUBMITTER: Lee MY 

PROVIDER: S-EPMC6517383 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

A biological function based biomarker panel optimization process.

Lee Min Young MY   Kim Taek-Kyun TK   Walters Kathie-Anne KA   Wang Kai K  

Scientific reports 20190514 1


Implementation of multi-gene biomarker panels identified from high throughput data, including microarray or next generation sequencing, need to be adapted to a platform suitable in a clinical setting such as quantitative polymerase chain reaction. However, technical challenges when transitioning from one measurement platform to another, such as inconsistent measurement results can affect panel development. We describe a process to overcome the challenges by replacing poor performing genes during  ...[more]

Similar Datasets

| S-EPMC3696829 | biostudies-other
| S-EPMC5043446 | biostudies-literature
| S-EPMC6497525 | biostudies-literature
| S-EPMC3314566 | biostudies-literature
| S-EPMC8793078 | biostudies-literature
| S-EPMC6021342 | biostudies-literature
| S-EPMC4368610 | biostudies-literature
| S-EPMC7073850 | biostudies-literature
| S-EPMC7352295 | biostudies-literature
| S-EPMC5225423 | biostudies-literature